BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ioannidis JPA, Bossuyt PMM. Waste, Leaks, and Failures in the Biomarker Pipeline. Clinical Chemistry 2017;63:963-72. [DOI: 10.1373/clinchem.2016.254649] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Lind GE, van Engeland M. Details matter: the role of genomic location and assay standardization in DNA methylation analyses. Epigenomics 2017;9:933-5. [PMID: 28617096 DOI: 10.2217/epi-2017-0053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Traldi P, Crotti S, D'aronco S. Some Applications of Liquid Chromatography-Mass Spectrometry in the Biomedical Field. Advances in the Use of Liquid Chromatography Mass Spectrometry (LC-MS) - Instrumentation Developments and Applications. Elsevier; 2018. pp. 329-75. [DOI: 10.1016/bs.coac.2017.09.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Beutgen VM, Perumal N, Pfeiffer N, Grus FH. Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA). Front Immunol 2019;10:381. [PMID: 30899261 DOI: 10.3389/fimmu.2019.00381] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
4 Rus CM, Di Bucchianico S, Cozma C, Zimmermann R, Bauer P. Dried Blood Spot (DBS) Methodology Study for Biomarker Discovery in Lysosomal Storage Disease (LSD). Metabolites 2021;11:382. [PMID: 34199226 DOI: 10.3390/metabo11060382] [Reference Citation Analysis]
5 Castelli FA, Rosati G, Moguet C, Fuentes C, Marrugo-Ramírez J, Lefebvre T, Volland H, Merkoçi A, Simon S, Fenaille F, Junot C. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests. Anal Bioanal Chem 2021. [PMID: 34432105 DOI: 10.1007/s00216-021-03586-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Calanzani N, Druce PE, Snudden C, Milley KM, Boscott R, Behiyat D, Saji S, Martinez-Gutierrez J, Oberoi J, Funston G, Messenger M, Emery J, Walter FM. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Adv Ther 2021;38:793-834. [PMID: 33306189 DOI: 10.1007/s12325-020-01571-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Denaxas S, Shah AD, Mateen BA, Kuan V, Quint JK, Fitzpatrick N, Torralbo A, Fatemifar G, Hemingway H. A semi-supervised approach for rapidly creating clinical biomarker phenotypes in the UK Biobank using different primary care EHR and clinical terminology systems. JAMIA Open 2020;3:545-56. [PMID: 33619467 DOI: 10.1093/jamiaopen/ooaa047] [Reference Citation Analysis]
8 Trepanowski JF, Ioannidis JPA. Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How. Adv Nutr 2018;9:367-77. [PMID: 30032218 DOI: 10.1093/advances/nmy014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
9 Halligan S, Kenis SF, Abeyakoon O, Plumb AAO, Mallett S. How to avoid describing your radiological research study incorrectly. Eur Radiol 2020;30:4648-55. [PMID: 32086575 DOI: 10.1007/s00330-020-06720-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Koch A, Joosten SC, Feng Z, de Ruijter TC, Draht MX, Melotte V, Smits KM, Veeck J, Herman JG, Van Neste L, Van Criekinge W, De Meyer T, van Engeland M. Analysis of DNA methylation in cancer: location revisited. Nat Rev Clin Oncol 2018;15:459-66. [PMID: 29666440 DOI: 10.1038/s41571-018-0004-4] [Cited by in Crossref: 154] [Cited by in F6Publishing: 155] [Article Influence: 51.3] [Reference Citation Analysis]
11 Katz L, Tata A, Woolman M, Zarrine-Afsar A. Lipid Profiling in Cancer Diagnosis with Hand-Held Ambient Mass Spectrometry Probes: Addressing the Late-Stage Performance Concerns. Metabolites 2021;11:660. [PMID: 34677375 DOI: 10.3390/metabo11100660] [Reference Citation Analysis]
12 Laugsand EA, Brenne SS, Skorpen F. DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples. Int J Colorectal Dis 2021;36:239-51. [PMID: 33030559 DOI: 10.1007/s00384-020-03757-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Trifonova OP, Maslov DL, Balashova EE, Lokhov PG. Mass spectrometry-based metabolomics diagnostics - myth or reality? Expert Rev Proteomics 2021;18:7-12. [PMID: 33653222 DOI: 10.1080/14789450.2021.1893695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lommen K, Vaes N, Aarts MJ, van Roermund JG, Schouten LJ, Oosterwijk E, Melotte V, Tjan-heijnen VC, van Engeland M, Smits KM. Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review. European Urology Oncology 2021;4:215-26. [DOI: 10.1016/j.euo.2019.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Pouw J, Leijten E, Radstake T, Boes M. Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: A review of literature. Clinical Immunology 2020;211:108318. [DOI: 10.1016/j.clim.2019.108318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Matzke LA, Watson PH. Biobanking for Cancer Biomarker Research: Issues and Solutions. Biomark Insights 2020;15:1177271920965522. [PMID: 33192050 DOI: 10.1177/1177271920965522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Binetti M, Lauro A, Vaccari S, Cervellera M, Tonini V. Proteogenomic biomarkers in colorectal cancers: clinical applications. Expert Review of Proteomics 2020;17:355-63. [DOI: 10.1080/14789450.2020.1782202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Furlani IL, da Cruz Nunes E, Canuto GAB, Macedo AN, Oliveira RV. Liquid Chromatography-Mass Spectrometry for Clinical Metabolomics: An Overview. Adv Exp Med Biol 2021;1336:179-213. [PMID: 34628633 DOI: 10.1007/978-3-030-77252-9_10] [Reference Citation Analysis]
19 Aboy M, Liddell K, Crespo C, Cohen IG, Liddicoat J, Gerke S, Minssen T. How does emerging patent case law in the US and Europe affect precision medicine? Nat Biotechnol 2019;37:1118-25. [DOI: 10.1038/s41587-019-0265-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
20 Eskes ECB, Sjouke B, Vaz FM, Goorden SMI, van Kuilenburg ABP, Aerts JMFG, Hollak CEM. Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers. Mol Genet Metab 2020;130:16-26. [PMID: 32088119 DOI: 10.1016/j.ymgme.2020.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Rush A, Matzke L, Cooper S, Gedye C, Byrne JA, Watson PH. Research Perspective on Utilizing and Valuing Tumor Biobanks. Biopreservation and Biobanking 2019;17:219-29. [DOI: 10.1089/bio.2018.0099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
22 Martí-Carvajal AJ, Gluud C, Arevalo-Rodriguez I, Martí-Amarista CE. Acetyl-L-carnitine for patients with hepatic encephalopathy. Cochrane Database Syst Rev 2019;1:CD011451. [PMID: 30610762 DOI: 10.1002/14651858.CD011451.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Byrne JA, Grima N, Capes-Davis A, Labbé C. The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions. Biomark Insights 2019;14:1177271919829162. [PMID: 30783377 DOI: 10.1177/1177271919829162] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
24 Armstrong D. Diagnosis: From classification to prediction. Soc Sci Med 2019;237:112444. [PMID: 31374408 DOI: 10.1016/j.socscimed.2019.112444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kochetov AG, Lyang OV, Zhirova IA, Ivoilov OO. [Laboratory diagnostics in medicine]. Ter Arkh 2020;92:4-8. [PMID: 32598691 DOI: 10.26442/00403660.2020.04.000501] [Reference Citation Analysis]
26 Frudd K, Sivaprasad S, Raman R, Krishnakumar S, Revathy YR, Turowski P. Diagnostic circulating biomarkers to detect vision-threatening diabetic retinopathy: Potential screening tool of the future? Acta Ophthalmol 2021. [PMID: 34269526 DOI: 10.1111/aos.14954] [Reference Citation Analysis]
27 Powles T, Walker J, Andrew Williams J, Bellmunt J. The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma. Cancer Treatment Reviews 2020;82:101925. [DOI: 10.1016/j.ctrv.2019.101925] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
28 Joosten SC, Smits KM, Aarts MJ, Melotte V, Koch A, Tjan-heijnen VC, van Engeland M. Epigenetics in renal cell cancer: mechanisms and clinical applications. Nat Rev Urol 2018;15:430-51. [DOI: 10.1038/s41585-018-0023-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
29 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
30 Graziadio S, Winter A, Lendrem BC, Suklan J, Jones WS, Urwin SG, O'Leary RA, Dickinson R, Halstead A, Kurowska K, Green K, Sims A, Simpson AJ, Power HM, Allen AJ. How to Ease the Pain of Taking a Diagnostic Point of Care Test to the Market: A Framework for Evidence Development. Micromachines (Basel) 2020;11:E291. [PMID: 32164393 DOI: 10.3390/mi11030291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
31 Fodale V, Boggio R, Daldin M, Cariulo C, Spiezia MC, Byrne LM, Leavitt BR, Wild EJ, Macdonald D, Weiss A, Bresciani A. Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay. J Huntingtons Dis 2017;6:349-61. [PMID: 29125493 DOI: 10.3233/JHD-170269] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
32 Monaghan PJ, Bossuyt PM. Test evaluation: major challengesahead - Opportunities abound. Ann Clin Biochem 2019;56:524-6. [PMID: 30971105 DOI: 10.1177/0004563219837301] [Reference Citation Analysis]
33 Steyerberg EW. Validation in prediction research: the waste by data splitting. J Clin Epidemiol 2018;103:131-3. [PMID: 30063954 DOI: 10.1016/j.jclinepi.2018.07.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
34 Bharucha T, Gangadharan B, Kumar A, de Lamballerie X, Newton PN, Winterberg M, Dubot-Pérès A, Zitzmann N. Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review. J Infect 2019;79:407-18. [PMID: 31404562 DOI: 10.1016/j.jinf.2019.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
35 Ritskes-Hoitinga M, Leenaars C, Beumer W, Coenen-de Roo T, Stafleu F, Meijboom FLB. Improving Translation by Identifying Evidence for More Human-Relevant Preclinical Strategies. Animals (Basel) 2020;10:E1170. [PMID: 32664195 DOI: 10.3390/ani10071170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Rosenfeld CR, Shafer G, Scheid LM, Brown LS. Screening and Serial Neutrophil Counts Do Not Contribute to the Recognition or Diagnosis of Late-Onset Neonatal Sepsis. The Journal of Pediatrics 2019;205:105-111.e2. [DOI: 10.1016/j.jpeds.2018.09.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Sun Y, Kim JH, Vangipuram K, Hayes DF, Smith EML, Yeomans L, Henry NL, Stringer KA, Hertz DL. Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy. Breast Cancer Res Treat 2018;171:657-66. [PMID: 29946863 DOI: 10.1007/s10549-018-4862-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
38 Considine EC. The Search for Clinically Useful Biomarkers of Complex Disease: A Data Analysis Perspective. Metabolites 2019;9:E126. [PMID: 31269649 DOI: 10.3390/metabo9070126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
39 Shuck SC, Nguyen C, Chan Y, O’connor T, Ciminera AK, Kahn M, Termini J. Metal-Assisted Protein Quantitation (MAPq): Multiplex Analysis of Protein Expression Using Lanthanide-Modified Antibodies with Detection by Inductively Coupled Plasma Mass Spectrometry. Anal Chem 2020;92:7556-64. [DOI: 10.1021/acs.analchem.0c00058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
40 Aikin R, Baume N, Equey T, Rabin O. Biomarkers of doping: uses, discovery and validation. Bioanalysis 2020;12:791-800. [DOI: 10.4155/bio-2020-0035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Zhang M, Dou H, Yang D, Shan M, Li X, Hao C, Zhang Y, Zeng P, He Y, Liu Y, Fu J, Wang W, Hu M, Li H, Tian Q, Lei S, Zhang L. Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years. Prog Mol Biol Transl Sci 2019;162:141-63. [PMID: 30905446 DOI: 10.1016/bs.pmbts.2019.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
42 Zhang L, Li D, Du F, Huang H, Yuan C, Fu J, Sun S, Tian T, Liu X, Sun H, Zhu L, Xu J, Liu Y, Cui B, Zhao Y. A panel of differentially methylated regions enable prognosis prediction for colorectal cancer. Genomics 2021;113:3285-93. [PMID: 34302946 DOI: 10.1016/j.ygeno.2021.07.010] [Reference Citation Analysis]
43 Kaprio T, Lindström AM, Rasila T, Saavalainen O, Beilmann-Lehtonen I, Mustonen H, Haglund C, Andersson LC. Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer. BMC Gastroenterol 2021;21:341. [PMID: 34481452 DOI: 10.1186/s12876-021-01918-y] [Reference Citation Analysis]
44 Ghannad M, Olsen M, Boutron I, Bossuyt PM. A systematic review finds that spin or interpretation bias is abundant in evaluations of ovarian cancer biomarkers. Journal of Clinical Epidemiology 2019;116:9-17. [DOI: 10.1016/j.jclinepi.2019.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
45 Lord SJ, St John A, Bossuyt PM, Sandberg S, Monaghan PJ, O'Kane M, Cobbaert CM, Röddiger R, Lennartz L, Gelfi C, Horvath AR; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine. Setting clinical performance specifications to develop and evaluate biomarkers for clinical use. Ann Clin Biochem 2019;56:527-35. [PMID: 30987429 DOI: 10.1177/0004563219842265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
46 You J, Kao A, Dillon R, Croner LJ, Benz R, Blume JE, Wilcox B. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers. J Proteomics 2018;187:80-92. [PMID: 29953963 DOI: 10.1016/j.jprot.2018.06.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
47 Dragani TA, Matarese V, Colombo F. Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics. Bioessays 2020;42:e1900122. [PMID: 32128843 DOI: 10.1002/bies.201900122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Al-Daghri NM, Batzel JJ, Burgmann H, Carbone F, Charmandari E, Chrousos GP, Distelmaier K, Cvirn G, Dullaart RPF, Dumitrascu DL, Esteve-Pastor MA, Gervasini G, Goliasch G, Goswami N, Gruppen EG, Hernández-Mijares A, Kalantaridou SN, Krause R, Latini R, Makrigiannakis A, Marín F, Masson S, Montecucco F, Ndrepepa G, Nicolaides NC, Novelli D, Orasan OH, Qorbani M, Ratzinger F, Roessler A, Sabico S, Sciatti E, Stefanaki C, Stoner L, Tabatabaei-Malazy O, Tatar E, Toz H, Uslu A, Victor VM, Vizzardi E. Research update for articles published in EJCI in 2015. Eur J Clin Invest 2017;47:775-88. [PMID: 28960328 DOI: 10.1111/eci.12819] [Reference Citation Analysis]
49 Retel Helmrich IRA, Lingsma HF, Turgeon AF, Yamal JM, Steyerberg EW. Prognostic Research in Traumatic Brain Injury: Markers, Modeling, and Methodological Principles. J Neurotrauma 2020. [PMID: 32316847 DOI: 10.1089/neu.2019.6708] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Vollmer S, Mateen BA, Bohner G, Király FJ, Ghani R, Jonsson P, Cumbers S, Jonas A, Mcallister KSL, Myles P, Grainger D, Birse M, Branson R, Moons KGM, Collins GS, Ioannidis JPA, Holmes C, Hemingway H. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness. BMJ. [DOI: 10.1136/bmj.l6927] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 27.5] [Reference Citation Analysis]
51 Parker SJ, Chen L, Spivia W, Saylor G, Mao C, Venkatraman V, Holewinski RJ, Mastali M, Pandey R, Athas G, Yu G, Fu Q, Troxlair D, Vander Heide R, Herrington D, Van Eyk JE, Wang Y. Identification of Putative Early Atherosclerosis Biomarkers by Unsupervised Deconvolution of Heterogeneous Vascular Proteomes. J Proteome Res 2020;19:2794-806. [PMID: 32202800 DOI: 10.1021/acs.jproteome.0c00118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
52 Kontostathi G, Makridakis M, Zoidakis J, Vlahou A. Applications of multiple reaction monitoring targeted proteomics assays in human plasma. Expert Rev Mol Diagn 2019;19:499-515. [PMID: 31057016 DOI: 10.1080/14737159.2019.1615448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
53 Hughes KS, Ambinder EP, Hess GP, Yu PP, Bernstam EV, Routbort MJ, Clemenceau JR, Hamm JT, Febbo PG, Domchek SM, Chen JL, Warner JL; OPO Workshop Members. Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop. JCO 2017;35:3153-9. [DOI: 10.1200/jco.2017.74.1744] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
54 Yekula A, Muralidharan K, Rosh ZS, Youngkin AE, Kang KM, Balaj L, Carter BS. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas. Adv Biosyst 2020;4:e2000029. [PMID: 32484293 DOI: 10.1002/adbi.202000029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
55 Plebani M. Biomarkers of acute kidney injury: a step forward. Clin Chem Lab Med 2017;55:1071-3. [PMID: 28593906 DOI: 10.1515/cclm-2017-0300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Patel PG, Wessel T, Kawashima A, Okello JBA, Jamaspishvili T, Guérard KP, Lee L, Lee AY, How NE, Dion D, Scarlata E, Jackson CL, Boursalie S, Sack T, Dunn R, Moussa M, Mackie/ K, Ellis A, Marra E, Chin J, Siddiqui K, Hetou K, Pickard LA, Arthur-Hayward V, Bauman G, Chevalier S, Brimo F, Boutros PC, Lapointe PhD J, Bartlett JMS, Gooding RJ, Berman DM. A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer. Prostate 2019;79:1705-14. [PMID: 31433512 DOI: 10.1002/pros.23895] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
57 Rhode H, Muckova P, Büchler R, Wendler S, Tautkus B, Vogel M, Moore T, Grosskreutz J, Klemm A, Nabity M. A next generation setup for pre-fractionation of non-denatured proteins reveals diverse albumin proteoforms each carrying several post-translational modifications. Sci Rep 2019;9:11733. [PMID: 31409882 DOI: 10.1038/s41598-019-48278-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Simons K. How Can Omic Science be Improved? Proteomics 2018;18:e1800039. [PMID: 29417741 DOI: 10.1002/pmic.201800039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
59 Dalton SGH, Cavanagh JF, Richardson JD. Spectral Resting-State EEG (rsEEG) in Chronic Aphasia Is Reliable, Sensitive, and Correlates With Functional Behavior. Front Hum Neurosci 2021;15:624660. [PMID: 33815079 DOI: 10.3389/fnhum.2021.624660] [Reference Citation Analysis]
60 Aydindogan E, Penque D, Zoidakis J. Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease. Expert Review of Molecular Diagnostics 2019;19:37-45. [DOI: 10.1080/14737159.2018.1559054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Mir IN, Steven Brown L, Rosenfeld CR, Chalak LF. Placental clearance/synthesis of neurobiomarkers GFAP and UCH-L1 in healthy term neonates and those with moderate-severe neonatal encephalopathy. Pediatr Res 2019;86:500-4. [PMID: 31132788 DOI: 10.1038/s41390-019-0439-z] [Reference Citation Analysis]
62 Lippi G, von Meyer A, Cadamuro J, Simundic A. PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:518-26. [DOI: 10.1515/cclm-2019-1089] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
63 Nijman RG, Oostenbrink R, Moll HA, Casals-Pascual C, von Both U, Cunnington A, De T, Eleftheriou I, Emonts M, Fink C, van der Flier M, de Groot R, Kaforou M, Kohlmaier B, Kuijpers TW, Lim E, Maconochie IK, Paulus S, Martinon-Torres F, Pokorn M, Romaine ST, Calle IR, Schlapbach LJ, Smit FJ, Tsolia M, Usuf E, Wright VJ, Yeung S, Zavadska D, Zenz W, Levin M, Herberg JA, Carrol ED; PERFORM consortium (Personalized Risk assessment in febrile children to optimize Real-life Management across the European Union). A Novel Framework for Phenotyping Children With Suspected or Confirmed Infection for Future Biomarker Studies. Front Pediatr 2021;9:688272. [PMID: 34395340 DOI: 10.3389/fped.2021.688272] [Reference Citation Analysis]
64 Mateen BA, Boakye N, Sonabend R, Russell N, Saverino A. The role of impulsivity in neurorehabilitation: A prospective cohort study of a potential cognitive biomarker for fall risk? J Neuropsychol 2021;15:379-95. [PMID: 33377618 DOI: 10.1111/jnp.12239] [Reference Citation Analysis]
65 Vedeld HM, Goel A, Lind GE. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives. Semin Cancer Biol. 2018;51:36-49. [PMID: 29253542 DOI: 10.1016/j.semcancer.2017.12.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
66 Draht MXG, Goudkade D, Koch A, Grabsch HI, Weijenberg MP, van Engeland M, Melotte V, Smits KM. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clin Epigenetics 2018;10:35. [PMID: 29564023 DOI: 10.1186/s13148-018-0461-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
67 Olsen M, Ghannad M, Lok C, Bossuyt PM. Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;58:3-10. [DOI: 10.1515/cclm-2019-0038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
68 Druce P, Calanzani N, Snudden C, Milley K, Boscott R, Behiyat D, Martinez-Gutierrez J, Saji S, Oberoi J, Funston G, Messenger M, Walter FM, Emery J. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. Adv Ther 2021;38:3032-65. [PMID: 33907946 DOI: 10.1007/s12325-021-01645-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Janiaud P, Serghiou S, Ioannidis JP. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. Cancer Treatment Reviews 2019;73:20-30. [DOI: 10.1016/j.ctrv.2018.12.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 17.3] [Reference Citation Analysis]
70 Koncina E, Haan S, Rauh S, Letellier E. Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges. Cancers (Basel). 2020;12. [PMID: 32019056 DOI: 10.3390/cancers12020319] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
71 Liu X, Hoene M, Yin P, Fritsche L, Plomgaard P, Hansen JS, Nakas CT, Niess AM, Hudemann J, Haap M, Mendy M, Weigert C, Wang X, Fritsche A, Peter A, Häring HU, Xu G, Lehmann R. Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole Blood. Clin Chem 2018;64:810-9. [PMID: 29567661 DOI: 10.1373/clinchem.2017.277905] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
72 Gomolka M, Blyth B, Bourguignon M, Badie C, Schmitz A, Talbot C, Hoeschen C, Salomaa S. Potential screening assays for individual radiation sensitivity and susceptibility and their current validation state. Int J Radiat Biol 2020;96:280-96. [PMID: 31347938 DOI: 10.1080/09553002.2019.1642544] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
73 Baker MJ, Byrne HJ, Chalmers J, Gardner P, Goodacre R, Henderson A, Kazarian SG, Martin FL, Moger J, Stone N, Sulé-suso J. Clinical applications of infrared and Raman spectroscopy: state of play and future challenges. Analyst 2018;143:1735-57. [DOI: 10.1039/c7an01871a] [Cited by in Crossref: 97] [Cited by in F6Publishing: 32] [Article Influence: 24.3] [Reference Citation Analysis]
74 Liu D, Li Q, Zhang X, Wang H, Cao W, Li D, Xing W, Song M, Wang W, Meng Q, Wang Y. Systematic Review: Immunoglobulin G N -Glycans as Next-Generation Diagnostic Biomarkers for Common Chronic Diseases. OMICS: A Journal of Integrative Biology 2019;23:607-14. [DOI: 10.1089/omi.2019.0032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
75 Fullana MA, Abramovitch A, Via E, López-sola C, Goldberg X, Reina N, Fortea L, Solanes A, Buckley MJ, Ramella-cravaro V, Carvalho AF, Tortella-feliu M, Vieta E, Soriano-mas C, Lázaro L, Stein DJ, Fernández de la Cruz L, Mataix-cols D, Radua J. Diagnostic biomarkers for obsessive-compulsive disorder: A reasonable quest or ignis fatuus? Neuroscience & Biobehavioral Reviews 2020;118:504-13. [DOI: 10.1016/j.neubiorev.2020.08.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
76 Lommen K, Odeh S, Theije CC, Smits KM. Biobanking in Molecular Biomarker Research for the Early Detection of Cancer. Cancers (Basel) 2020;12:E776. [PMID: 32218259 DOI: 10.3390/cancers12040776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Yekula A, Muralidharan K, Kang KM, Wang L, Balaj L, Carter BS. From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers. Methods 2020;177:58-66. [PMID: 32061674 DOI: 10.1016/j.ymeth.2020.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
78 Tang Y, Cui Y, Zhang S, Zhang L. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection. Prog Mol Biol Transl Sci 2019;162:121-40. [PMID: 30905445 DOI: 10.1016/bs.pmbts.2019.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
79 Fortino V, Scala G, Greco D. Feature set optimization in biomarker discovery from genome-scale data. Bioinformatics 2020;36:3393-400. [PMID: 32119073 DOI: 10.1093/bioinformatics/btaa144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
80 Papadopoulou-marketou N, Kanaka-gantenbein C, Marketos N, Chrousos GP, Papassotiriou I. Biomarkers of diabetic nephropathy: A 2017 update. Critical Reviews in Clinical Laboratory Sciences 2017;54:326-42. [DOI: 10.1080/10408363.2017.1377682] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]